UG

Serial Number 90816013
Registration 7063031
700

Registration Progress

Application Filed
Jul 7, 2021
Under Examination
Sep 20, 2022
Approved for Publication
Jul 26, 2022
Published for Opposition
Jul 26, 2022
Registered
May 23, 2023

Trademark Image

UG

Basic Information

Serial Number
90816013
Registration Number
7063031
Filing Date
July 7, 2021
Registration Date
May 23, 2023
Published for Opposition
July 26, 2022
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
May 23, 2023
Registration
Registered
Classes
010 042

Rights Holder

Ultima Genomics, Inc.

03
Address
4209 Technology Drive
Fremont, CA 94538

Ownership History

Ultima Genomics, Inc.

Original Applicant
03
Newark, CA

Ultima Genomics, Inc.

Owner at Publication
03
Newark, CA

Ultima Genomics, Inc.

Original Registrant
03
Fremont, CA

Legal Representation

Attorney
Sheila Fox Morrison

USPTO Deadlines

Next Deadline
1204 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230523)
Due Date
May 23, 2029
Grace Period Ends
November 23, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

40 events
Date Code Type Description Documents
Dec 17, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 17, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 17, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 2, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 2, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 2, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 24, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 24, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 24, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 23, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 23, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 19, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 18, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Mar 25, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 13, 2023 IUAF S USE AMENDMENT FILED Loading...
Mar 25, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 13, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 20, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 26, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 26, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 6, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 21, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 1, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 31, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 31, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 4, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 4, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 4, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 25, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 18, 2022 APET A ASSIGNED TO PETITION STAFF Loading...
Jan 13, 2022 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Jan 13, 2022 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Jan 3, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 3, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 3, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 5, 2021 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Nov 5, 2021 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Sep 16, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 15, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 10, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 010
Clinical or medical diagnostic apparatus and instruments, namely, nucleic acid sequencers and analyzers; medical diagnostic apparatus and instruments for the amplification and analysis of nucleic acids and the preparation of nucleic acid libraries sold; medical equipment, namely, devices for analyzing nucleic acids and for DNA sequencing for the purpose of rendering medical treatment and diagnosis; apparatus for DNA and RNA testing for medical purposes; medical diagnostic instruments for the analysis of body fluids; sample preparation device for medical diagnostic uses; medical diagnostic apparatus for testing DNA and RNA samples
First Use Anywhere: 20200000
First Use in Commerce: 20200000
Class 042
Medical and scientific research in the field of genome sequence analysis and reporting; DNA screening for medical and scientific research purposes; design and development of laboratory apparatus, instruments and computer systems for use in testing DNA and RNA samples; product development, namely, developing equipment for use in preparing, detecting, analyzing, and sequencing nucleic acids and other biological molecules; clinical laboratory services in preparing, amplifying, labeling, detecting, analyzing, and sequencing nucleic acids and other biological molecules from human beings or animals for scientific and medical research purposes; design and development of medical diagnostic apparatus and instruments for use in genetic sequencing; scientific consulting and research services and clinical laboratory testing services in the fields of amplification, detection, sequencing, and analysis of nucleic acids and the preparation of nucleic acid libraries; nucleic acid sequencing services for medical and scientific research purposes; providing temporary use of non-downloadable computer software for scientific analysis of genetic sequences; providing temporary use of non-downloadable computer software for storing, organizing, and creating a searchable library of genetic data for use in sequence detection, and disease detection and diagnosis; providing temporary use of non-downloadable computer software for database management and for storage of electronic data; providing temporary use of non-downloadable computer software for creating searchable databases of information and data; providing temporary use of non-downloadable computer software for use in connection with databases in the field of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology, metagenomics, biotechnology, genetic testing, and genetics; providing temporary use of non-downloadable computer software for use in connection with medical research services in the field of genotyping, diagnostics, molecular pathology, molecular diagnostics, laboratory medicine, and oncology; providing temporary use of non-downloadable computer software for use in connection with DNA sequencing, screening, and analysis services for medical and scientific research purposes; providing temporary use of non-downloadable computer software for use in connection with nucleic acid sequencing, screening, and analysis services for medical and scientific research purposes; providing temporary use of non-downloadable computer software for use in connection with genomic sequencing, screening, and analysis services for medical and scientific research purposes; providing temporary use of non-downloadable computer software for use in connection with genetic analysis and reporting services for medical and scientific research purposes; providing temporary use of non-downloadable computer software for use in connection with next-generation sequencing (NGS) bioinformatics data processor in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; providing temporary use of non-downloadable computer software for compressing and decompressing genomic data files; providing temporary use of non-downloadable computer software, namely, software to receive and store DNA, RNA and genetic records, and to authorize medical and research personnel to use records
First Use Anywhere: 20200000
First Use in Commerce: 20200000

Additional Information

Design Mark
The mark consists of the stylized letters UG.

Classification

International Classes
010 042